BC
WVE icon

Birchview Capital’s Wave Life Sciences WVE Stock Holding History

Birchview Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,300
Closed -$262K – 78
2025
Q2 		$262K Hold
40,300
– – 0.26% 54
2025
Q1 		$326K Buy
40,300
+300
+0.8% +$3.28K 0.28% 42
2024
Q4 		$495K Hold
40,000
– – 0.4% 32
2024
Q3 		$328K Hold
40,000
– – 0.28% 42
2024
Q2 		$200K Hold
40,000
– – 0.18% 49
2024
Q1 		$247K Hold
40,000
– – 0.2% 50
2023
Q4 		$202K Buy
+40,000
New +$214K 0.16% 52

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Birchview Capital's WVE Position: Q3 2025 in Review

Birchview Capital sold out of Wave Life Sciences (WVE) in Q3 2025, closing a stake of 40,300 shares — an estimated $262K sold.

Birchview Capital first reported a position in WVE in Q4 2023 and held it in 7 quarters. The position peaked at $495K in Q4 2024. 189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

  • Birchview Capital reported no remaining Wave Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Birchview Capital sold 40,300 Wave Life Sciences shares in Q3 2025, an estimated $262K.
  • Birchview Capital first reported a position in Wave Life Sciences in Q4 2023 and held it in 7 quarters.
  • Birchview Capital's Wave Life Sciences position peaked at $495K in Q4 2024.
  • 189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on Birchview Capital's 13F filing for Q3 2025, filed 13 Nov 2025.